Skip to main content

MoneyWorks4Me

Kimia Biosciences gets permission to manufacture, market ‘Fimasartan Potassium Trihydrate API’

23 Jul 2020 Evaluate
Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Fimasartan Potassium Trihydrate API’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..